Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Simona Deiana, Tommaso Gabbani, Siro Bagnoli & Vito Annese. (2015) Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opinion on Emerging Drugs 20:2, pages 247-261.
Read now
Read now
Allen W Mangel & Gareth A Hicks. (2012) Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. Clinical and Experimental Gastroenterology 5, pages 1-10.
Read now
Read now
Articles from other publishers (13)
Federica Santino & Luca Gentilucci. (2023) Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects. Molecules 28:1, pages 346.
Crossref
Crossref
Md Imdadul H. Khan, Benjamin J. Sawyer, Nicholas S. Akins & Hoang V. Le. (2022) A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse. European Journal of Medicinal Chemistry 243, pages 114785.
Crossref
Crossref
Anne-Cécile Van Baelen, Philippe Robin, Pascal Kessler, Arhamatoulaye Maïga, Nicolas Gilles & Denis Servent. (2022) Structural and Functional Diversity of Animal Toxins Interacting With GPCRs. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Veena D. Yadav, Lalan Kumar, Poonam Kumari, Sakesh Kumar, Maninder Singh, Mohammad I. Siddiqi, Prem N. Yadav & Sanjay Batra. (2021) Synthesis and Assessment of Fused β‐Carboline Derivatives as Kappa Opioid Receptor Agonists. ChemMedChem 16:12, pages 1917-1926.
Crossref
Crossref
Xin Li, Hong Wan, Ping Dong, Bin Wang, Lei Zhang, Qiyue Hu, Ting Zhang, Jun Feng, Feng He, Chang Bai, Lianshan Zhang & Weikang Tao. (2020) Discovery of SHR0687, a Highly Potent and Peripheral Nervous System-Restricted KOR Agonist. ACS Medicinal Chemistry Letters 11:11, pages 2151-2155.
Crossref
Crossref
Agata Szymaszkiewicz, Martin Storr, Jakub Fichna & Marta Zielinska. (2018) Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders. Neurogastroenterology & Motility 31:4, pages e13526.
Crossref
Crossref
Halina Machelska & Melih Ö. Celik. (2018) Advances in Achieving Opioid Analgesia Without Side Effects. Frontiers in Pharmacology 9.
Crossref
Crossref
Gema Tarrasón, Carla Carcasona, Peter Eichhorn, Bibiana Pérez, Amadeu Gavaldà & Núria Godessart. (2017) Characterization of the chloroquine‐induced mouse model of pruritus using an automated behavioural system. Experimental Dermatology 26:11, pages 1105-1111.
Crossref
Crossref
Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza & Michael Eldon. (2017)
Pharmacologic Profile of Naloxegol, a Peripherally Acting
µ
-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
. Journal of Pharmacology and Experimental Therapeutics 361:2, pages 280-291.
Crossref
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Crossref
O. Yu. Grechko, A. A. Spasov & D. M. Shtareva. (2016) Opioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs. Pharmaceutical Chemistry Journal 50:1, pages 1-9.
Crossref
Crossref
Andreas Brust, Daniel E. Croker, Barbara Colless, Lotten Ragnarsson, Åsa Andersson, Kapil Jain, Sonia Garcia-Caraballo, Joel Castro, Stuart M Brierley, Paul F. Alewood & Richard J. Lewis. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties. Journal of Medicinal Chemistry 59:6, pages 2381-2395.
Crossref
Crossref
Pradip K. Sasmal, C. Vamsee Krishna, S. Sudheerkumar Adabala, M. Roshaiah, Khaji Abdul Rawoof, Emima Thadi, K. Pavan Sukumar, Srisailam Cheera, Chandrasekhar Abbineni, K.V.L. Narasimha Rao, A. Prasanthi, Kamal Nijhawan, Mahaboobi Jaleel, Lakshmi Ramachandran Iyer, T. Krishna Chaitanya, Nirbhay Kumar Tiwari, N. Lavanya Krishna, Vijay Potluri, Ish Khanna, Thomas M. Frimurer, Michael Lückmann, Øystein Rist, Lisbeth Elster & Thomas Högberg. (2015) Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters 25:4, pages 887-892.
Crossref
Crossref